November 30, 2024 - 10:12

Investors are always on the lookout for stocks that show potential for significant growth over the long term. One key indicator to consider is the return on capital, which can provide insights into a company's efficiency and profitability. Recent trends suggest that certain companies are beginning to exhibit strong returns on capital, signaling a bright future ahead.
When evaluating a stock, it’s crucial to analyze its financial statements and key performance indicators. Look for companies with a consistent track record of increasing their return on capital, as this often indicates sound management and a robust business model. Additionally, consider the overall market conditions and how they may impact the company's growth prospects.
Another factor to watch is innovation within the company. Firms that invest in research and development tend to stay ahead of the competition and create new revenue streams. By keeping an eye on these early trends, investors can position themselves to capitalize on stocks that have the potential to multiply in value over time.
August 11, 2026 - 19:51
New Bedford police to temporarily suspend use of Flock technologyNew Bedford Police Chief Jason Thody announced on Tuesday that the department will temporarily stop using its Flock Safety camera technology. The decision comes after weeks of public debate and...
August 11, 2026 - 03:59
Shake Shack says tech glitch explains viral no-tip videoShake Shack is speaking out after a customer`s receipt from one of its airport stands sparked a heated online debate. The company says a technology malfunction, not a change in policy, is behind...
August 10, 2026 - 23:17
Insider Sale: SVP Information Technology of $TTMI Sells 26,198 SharesDale Martin Knecht, the Senior Vice President of Information Technology at TTMI, has sold a significant portion of his holdings in the company. According to a recent filing with the Securities and...
August 10, 2026 - 07:34
Building Scalable, Reliable AAV Gene Therapy ManufacturingGene therapy is at a turning point. The FDA recently granted a regenerative medicine advanced therapy designation to ELVECTA, a candidate for a rare genetic disorder. That designation speeds up...